Core Viewpoint - The Rosen Law Firm is encouraging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to misleading financial statements and practices during the Class Period from May 16, 2024, to August 5, 2025 [2][6]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements between subsidiaries [6]. - The lawsuit claims that these misleading statements resulted in investor damages when the true details became public [6]. Group 2: Next Steps for Investors - To join the class action, investors can visit the provided link or contact the law firm directly for more information [4][7]. - A lead plaintiff must be appointed by December 8, 2025, to represent other class members in the litigation [4]. - Investors have the option to select their counsel or remain absent from the class at this stage [8]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [5]. - The firm was ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions for investors over the years [5].

Frost & Sullivan Presents Haohai Biological Technology with the "2025 Global Premium Hyaluronic Acid Technology Leadership Award"November 24, 2025 10:27 PM EST | Source: HmediumShanghai, China--(Newsfile Corp. - November 24, 2025) - On the evening of August 27, the 2025 Frost & Sullivan Global Growth, Innovation & Leadership Awards, China Awards, and Best Practice Awards were grandly unveiled at the Frost & Sullivan Global Growth, Innovation and Leadership Award Ceremony 2025 and VIP Client Ap ...

Core Insights - The "2025 Blue Book on the Current Status and Trends of Global Expansion of Chinese Medical Devices" provides a comprehensive analysis of the Chinese medical device industry's growth, challenges, and opportunities in global markets [1][6]. Group 1: Market Overview - China's medical device market size increased from 729.8 billion RMB in 2020 to 941.7 billion RMB in 2024, reflecting a CAGR of 6.6% [1]. - The global medical device market grew from 456.6 billion USD to 623.0 billion USD during the same period, achieving a CAGR of 8.1% [2]. Group 2: Drivers of Global Expansion - Internal factors driving the global expansion of Chinese medical device companies include intense domestic competition, centralized procurement policies leading to price pressures, and improvements in R&D and innovation capabilities [3]. - External factors include a broad global market for medical devices, price competitiveness of Chinese products, and the rising global influence of China [3]. Group 3: Historical Context and Trends - Early Chinese medical device companies focused on basic healthcare segments, leveraging cost advantages to export low-value consumables post-WTO accession in 2001 [4]. - The pandemic accelerated globalization for companies in molecular diagnostics, with a shift towards mid-high-end markets to enhance competitiveness by 2023 [4]. Group 4: Value Chain and Strategies - The medical device value chain encompasses R&D, manufacturing, distribution, and sales, forming a global ecosystem that enhances market reach and patient impact [5]. - Strategies for global expansion include various distribution models, overseas manufacturing, and mergers and acquisitions, with case studies illustrating successful paths [8]. Group 5: Sub-sector and Regional Analysis - The Blue Book includes a sub-sector analysis covering life support equipment, medical imaging, vascular intervention products, and more, assessing their current states and prospects [8]. - Regional analysis addresses the macroeconomics, medical insurance systems, and regulatory requirements in key markets such as the U.S., EU, Japan, and regions involved in the Belt and Road Initiative [8]. Group 6: Challenges and Solutions - Key difficulties in global expansion include unclear direction, inaccurate market assessments, and a lack of understanding of market access procedures [8]. - Solutions involve increased R&D investment, alignment with international standards, and improved cross-cultural communication [8].

Private GP Clinic Sloane Street Surgery Marks One Year of Same-Day Diagnostic Testing, Transforming Infection Care for London PatientsSloane Street Surgery's BioFire testing provides same-day identification of infections, allowing faster, safer and more targeted treatmentNovember 24, 2025 10:15 PM EST | Source: PlentisoftLondon, United Kingdom--(Newsfile Corp. - November 24, 2025) - Sloane Street Surgery is marking one year since introducing same-day BioFire diagnostic testing, a rapid molecul ...

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 2, 2025 [3]. - The lawsuit alleges that Molina failed to disclose critical information regarding its medical cost trend assumptions and the impact on its financial guidance for fiscal year 2025 [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Specifics - The lawsuit claims that Molina's near-term growth was reliant on a lack of utilization of various health services, which was not disclosed to investors [5]. - The misleading positive statements made by Molina regarding its business operations and prospects are central to the claims in the lawsuit [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of CarMax, Inc. to secure counsel before the January 2, 2026 deadline for a securities class action lawsuit related to misleading statements made by the company during the class period from June 20, 2025, to November 5, 2025 [2][6]. Group 1: Class Action Details - Investors who purchased CarMax securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 2, 2026, to represent other class members [4][6]. - The lawsuit alleges that CarMax made materially false and misleading statements regarding its growth prospects, which were based on temporary market conditions rather than sustainable business performance [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in achieving significant settlements for investors [5]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions of dollars for investors [5].

Vancouver, British Columbia--(Newsfile Corp. - November 24, 2025) - 4 Touchdowns Capital Inc. ("4TC" or the "Company") announces that it has applied to the British Columbia Securities Commission ("BCSC") for a partial revocation of the failure-to-file cease trade order that was issued by the BCSC against the Company on May 6, 2025 (the "FFCTO") for failing to file certain outstanding continuous disclosure documents in a timely manner (the "Partial Revocation Order").If the Partial Revocation Order is grant ...

Core Points - Powermax Minerals Inc. has amended the exercise period of its warrants from 24 months to 36 months at an exercise price of $0.95 per share [1] - The private placement units are being offered at a price of $0.76 per unit, with all other terms remaining unchanged from the previous announcement [1] Company Overview - Powermax Minerals Inc. is a Canadian mineral exploration company focused on rare earth element projects [3] - The company holds an option to acquire the Cameron REE Property, which consists of three mineral claims totaling approximately 2,984 hectares in British Columbia [3] - Additionally, Powermax has an option to acquire the Atikokan REE Property, comprising 455 unpatented mining claims in Northwestern Ontario, and owns a 100% interest in the Ogden Bear Lodge Project located in Crook County, Wyoming [3]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Jayud Global Logistics Ltd. during the specified Class Period, highlighting potential compensation opportunities for affected investors [2][3]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between April 21, 2023, and April 30, 2025, and investors must act by January 20, 2026, to serve as lead plaintiff [2][4]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Allegations Against Jayud - The lawsuit alleges that Jayud made materially false and misleading statements, failed to disclose involvement in a fraudulent stock promotion scheme, and omitted critical information regarding stock price manipulation [6]. - Specific allegations include the use of offshore accounts for coordinated share dumping and misleading public statements about the company's business and operations [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [5].

Core Points - Canamera Energy Metals Corp. has successfully closed a non-brokered private placement, raising approximately $2,473,570.35 for advancing mineral projects and general corporate purposes [1][2] - The company also completed a LIFE Offering, issuing 4,394,356 units at a price of $0.45 per unit, generating gross proceeds of about $1,977,460.20 [3][5] - The company has changed its auditor from Adam Sung Kim Ltd. to DeVisser Gray LLP effective November 17, 2025 [7][9] Private Placement Details - The private placement included the issuance of 1,782,000 flow-through units at $0.56 each and 3,279,223 non-flow-through units at $0.45 each [8] - The proceeds from the sale of flow-through units will be used for Canadian exploration expenses as defined by the Income Tax Act (Canada) [1] - Finder's fees of $22,153.20 were paid in cash, along with 46,560 finder's warrants issued to Research Capital Corporation [2] LIFE Offering Details - Each LIFE Unit consists of one common share and one-half of a common share purchase warrant, with warrants exercisable at $0.56 for 36 months [3][5] - The LIFE Offering was conducted under the Listed Issuer Financing Exemption, meaning the units are not subject to a hold period [4] - Finder's fees of $65,078.10 were paid in cash, along with 144,618 finder's warrants issued to Research Capital Corporation [5] Auditor Change - The resignation of the predecessor auditor was at the company's request, and the new auditor will serve until the next Annual General Meeting [9] - There were no reservations in the predecessor auditor's reports for the most recently completed fiscal year or any subsequent periods [10] - The notice of change of auditor has been filed on SEDAR+ as required [11] Company Overview - Canamera is focused on mineral exploration, particularly in acquiring and developing projects in underexplored regions, including the Mantle project in British Columbia [12]